{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": "Zimmerman_et_al.__2023_",
  "additional_evidence_check": {
    "checked_for_more": true,
    "found_additional": true,
    "additional_count": 1
  },
  "completeness_stats": {
    "existing_evidence": 1,
    "new_evidence_found": 1,
    "total_evidence": 1
  },
  "combined_evidence": [
    {
      "id": 1,
      "quote": "because it is not subject to mutations to the A (H3 N2) glycosylation binding site that reduce the effectiveness of egg based vaccines.",
      "relevance_explanation": "This quote explicitly states that egg-based vaccines can develop mutations at the A (H3 N2) glycosylation binding site, which can reduce their effectiveness. This directly supports the claim that mutations during production may impact vaccine efficacy."
    }
  ],
  "completeness_assessment": {
    "missing_aspects": []
  },
  "model_used": "gpt-4.1"
}